Scientific Frontline: Extended "At a Glance" Summary: Negative Hysteresis in Antibiotic Sensitization
The Core Concept: Negative hysteresis is an evolution-informed treatment strategy where an initial exposure to one antibiotic predictably induces a temporary cellular vulnerability in a bacterial pathogen to a second, different antibiotic. In the pathogen Pseudomonas aeruginosa, pretreatment with a β-lactam robustly sensitizes the bacteria to a subsequent aminoglycoside attack.
Key Distinction/Mechanism: Unlike traditional combination therapies or chance collateral sensitivity, negative hysteresis actively induces a compromised cellular state. The initial β-lactam triggers the Cpx envelope stress response system, which damages the bacterial cell membrane and forces an elevated cellular uptake of the incoming aminoglycoside, effectively overriding existing resistance mechanisms.
Major Frameworks/Components:
- Sequential Therapy: Administering specific drugs in a staggered, time-controlled timeline to manipulate bacterial adaptation and vulnerability.
- The Cpx Envelope Stress Response: A critical sensory and regulatory system in bacteria that manages membrane stress and inadvertently regulates the lethal uptake of subsequent antibiotics.
- Evolutionary Therapeutics: Utilizing the principles of evolutionary biology to predict, direct, and constrain a pathogen's ability to mutate and survive.
- Genomic Diversity Targeting: Ensuring the sensitization strategy is robust enough to succeed universally across various genetically distinct and highly resistant strains of a single pathogen.
.png)













.jpg)